JP2004505932A5 - - Google Patents

Download PDF

Info

Publication number
JP2004505932A5
JP2004505932A5 JP2002517105A JP2002517105A JP2004505932A5 JP 2004505932 A5 JP2004505932 A5 JP 2004505932A5 JP 2002517105 A JP2002517105 A JP 2002517105A JP 2002517105 A JP2002517105 A JP 2002517105A JP 2004505932 A5 JP2004505932 A5 JP 2004505932A5
Authority
JP
Japan
Prior art keywords
product
lactoferrin
labeled
tumor
product according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002517105A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004505932A (ja
Filing date
Publication date
Priority claimed from GBGB0019412.6A external-priority patent/GB0019412D0/en
Application filed filed Critical
Publication of JP2004505932A publication Critical patent/JP2004505932A/ja
Publication of JP2004505932A5 publication Critical patent/JP2004505932A5/ja
Pending legal-status Critical Current

Links

JP2002517105A 2000-08-08 2001-08-07 造影剤としての放射性標識金属輸送タンパク質 Pending JP2004505932A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0019412.6A GB0019412D0 (en) 2000-08-08 2000-08-08 New imaging agent
PCT/GB2001/003531 WO2002011772A2 (en) 2000-08-08 2001-08-07 Radiolabelled metal transport proteins as imaging agents

Publications (2)

Publication Number Publication Date
JP2004505932A JP2004505932A (ja) 2004-02-26
JP2004505932A5 true JP2004505932A5 (enExample) 2005-03-03

Family

ID=9897174

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002517105A Pending JP2004505932A (ja) 2000-08-08 2001-08-07 造影剤としての放射性標識金属輸送タンパク質

Country Status (7)

Country Link
US (2) US7160536B2 (enExample)
EP (1) EP1307240A2 (enExample)
JP (1) JP2004505932A (enExample)
AU (1) AU2001278585A1 (enExample)
CA (1) CA2418383A1 (enExample)
GB (1) GB0019412D0 (enExample)
WO (1) WO2002011772A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0019412D0 (en) * 2000-08-08 2000-09-27 Univ York New imaging agent
JP2005517042A (ja) * 2002-02-12 2005-06-09 ヴィスタテック・ヨーク・リミテッド 生体分子を放射性標識する方法
WO2006047744A2 (en) 2004-10-26 2006-05-04 Agennix Incorporated Compositions of lactoferrin related peptides and uses thereof
DE102005051366A1 (de) * 2005-10-25 2007-04-26 Degussa Gmbh Drug Delivery Systeme
JP5264492B2 (ja) * 2005-10-25 2013-08-14 エボニック デグサ ゲーエムベーハー 超分岐ポリマーを含有する調製物
EP1982698A1 (de) * 2007-04-18 2008-10-22 Evonik Degussa GmbH Präparate zur gesteuerten Freisetzung von bioaktiven Naturstoffen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4057617A (en) 1975-05-15 1977-11-08 Abramovici J Method of labeling proteins with technetium
FI950062A7 (fi) * 1992-07-06 1995-01-05 Biomira Inc Proteiinien foroaktivaatio konjugaatiotarkoituksia varten
GB0019412D0 (en) * 2000-08-08 2000-09-27 Univ York New imaging agent

Similar Documents

Publication Publication Date Title
JP3853354B2 (ja) 放射性標識ペプチドおよびタンパク質の自己放射線分解を防止する安定剤
Gaynor et al. The prevalence of metal-based drugs as therapeutic or diagnostic agents: beyond platinum
JP7242538B2 (ja) 放射線治療及び画像診断のための製剤
ES2736134T3 (es) Derivado peptídico de tiourea, compuesto marcado con radioisótopos que contiene el mismo y composición farmacéutica que contiene el mismo como ingrediente activo para tratar o diagnosticar el cáncer de próstata
US4500507A (en) Diagnostic composition for radiologic imaging of neoplasms in the body and method of preparation
RU2594167C2 (ru) Композиции пептидных радиоактивных индикаторов
KR20050119205A (ko) 갈륨-68을 얻는 방법, 갈륨-68의 용도 및 상기 방법의수행을 위한 장치
JPH10500411A (ja) ソマトスタチン結合性ペプチド−金属キレートコンジュゲート
JP3558169B2 (ja) 新規化合物及びその製造方法並びに診断用薬剤
US20130330276A1 (en) Conjugate of human albumin and 2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid useful for the localization of radionuclides for diagnostic and therapeutic purposes
KR0175305B1 (ko) 방사능의약품 조성물의 제조방법
CN117159753A (zh) 放射性标记的伊文思蓝衍生物药物的制备方法及用途
JP2000515847A (ja) ペプチド放射性医薬品用途
Zhao et al. 68Ga-labeled dimeric and trimeric cyclic RGD peptides as potential PET radiotracers for imaging gliomas
JPH06502640A (ja) テクネチウム−99m錯化合物の放射性医薬としての使用
Mukiza et al. A review on technetium and rhenium based radiopharmaceuticals for diagnostic imaging and therapeutic nuclear medicine
CN1771058A (zh) 制备放射性标记的镓络合物的微波方法
Ferro-Flores et al. Radiolabeled protein-inhibitor peptides with rapid clinical translation towards imaging and therapy
RU2568888C1 (ru) СПОСОБ И СОСТАВ ДЛЯ ПОЛУЧЕНИЯ РЕАГЕНТА ДЛЯ РАДИОНУКЛИДНОЙ ДИАГНОСТИКИ НА ОСНОВЕ МЕЧЕННОЙ ТЕХНЕЦИЕМ-99m 5-ТИО-D-ГЛЮКОЗЫ
Garnuszek et al. Evaluation of a freeze-dried kit for EDTMP-based bone-seeking radiopharmaceuticals
JP7802851B2 (ja) 放射性標識されたgprpアンタゴニスト及び界面活性剤を含む医薬組成物
KR20070106731A (ko) 방사성표지된 갈륨 복합체, 그의 합성방법 및 악성종양에서 egfr 발현의 pet 영상화를 위한 그의 용도
WO2023202730A2 (zh) 放射性伊文思蓝衍生物药物水溶液及其制备方法和用途
RU2013113677A (ru) Визуализирующие апоптоз агенты на основе лантибиотических пептидов
JP2003535005A (ja) 過テクネチウム酸塩および過レニウム酸塩の還元剤としてスズイオンを使用するTcおよびReカルボニル錯体の処方